Directly Acting Oral Anticoagulants for the Prevention of Stroke in Atrial Fibrillation in England and Wales: Cost-Effectiveness Model and Value of Information Analysis

Objectives. Determine the optimal, licensed, first-line anticoagulant for prevention of ischemic stroke in patients with non-valvular atrial fibrillation (AF) in England and Wales from the UK National Health Service (NHS) perspective and estimate value to decision making of further research. Methods...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:MDM Policy Pract
Autors principals: Thom, Howard H. Z., Hollingworth, Will, Sofat, Reecha, Wang, Zhenru, Fang, Wei, Bodalia, Pritesh N., Bryden, Peter A., Davies, Philippa A., Caldwell, Deborah M., Dias, Sofia, Eaton, Diane, Higgins, Julian P. T., Hingorani, Aroon D., Lopez-Lopez, Jose A., Okoli, George N., Richards, Alison, Salisbury, Chris, Savović, Jelena, Stephens-Boal, Annya, Sterne, Jonathan A. C., Welton, Nicky J.
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6699015/
https://ncbi.nlm.nih.gov/pubmed/31453363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2381468319866828
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars